Thomas Reidy

Thomas Reidy is a seasoned executive with extensive experience in the medical device and diagnostic sectors. Currently serving as Chief Executive Officer at Ensite Vascular LLC and President and CEO of EnsiteVascular™ since 2010, Reidy has led innovative advancements in medical devices, specifically SiteSeal® and SiteSeal® SV™, addressing hemostasis challenges for endovascular procedures. Previously, as President and CEO of Primus Corporation from 1996 to 2008, Reidy transformed a struggling company into a recognized leader through strategic reorganization, market entry initiatives, and successful product development. Their earlier roles include Co-Founder and Vice President of Sales and Marketing at Immuno Biotech, where Thomas developed market strategies for novel medical products, and Co-Founder and Vice President of Marketing and Sales at Allergy and Immuno Diagnostics Laboratories, where Thomas positioned the company for acquisition. Reidy holds an MBA in Finance from The Ohio State University and a BS in Marketing from Indiana University - Kelley School of Business.